B/BE/22/BVW5 - Information sheet for the public (prepared by the notifier)

Trial reference: 
A two-part, open-label systemic gene delivery study to evaluate the safety and expression of RO7494222 (SRP-9001) in subjects under the age of four with Duchennne Muscular Dystrophy (ENVOL)